References
- Papers of special note have been highlighted as:
- • of interest
- •• of considerable interest
- Kass MA, Meltzer DW, Gordon M, et al. Compliance with topical pilocarpine treatment. Am J Ophthalmol. 1986;101:515–523.
- Leske MC, Heijl A, Hussein M, et al. Early Manifest Glaucoma Trial G. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121:48–56.
- Heijl A, Leske MC, Bengtsson B, et al. Early Manifest Glaucoma Trial G. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268–1279.
- Garway-Heath DF, Crabb DP, Bunce C, et al. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet. 2015;385:1295–1304.
- Schwartz GF, Quigley HA. Adherence and persistence with glaucoma therapy. Surv Ophthalmol. 2008;53(Suppl1):S57–S68.
- Reardon G, Kotak S, Schwartz GF. Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review. Patient Prefer Adherence. 2011;5:441–463.
• Excellent review of the current status of medication adherence for glaucoma patients.
- Olthoff CM, Schouten JS, Van De Borne BW, et al. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmology. 2005;112:953–961.
- Newman-Casey PA, Blachley T, Lee PP, et al. Patterns of glaucoma medication adherence over four years of follow-up. Ophthalmology. 2015;122(10):2010–2021.
- Sabate E. Adherence to long-term therapies: evidence for action. Geneva, Switzerland: World Health Organization (WHO); 2003. [cited 2015 June 7]. Available from: http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf
• World Health Organization analysis of the barrier of adherence to chronic medications.
- Newman-Casey PA, Weizer JS, Heisler M, et al. Systematic review of educational interventions to improve glaucoma medication adherence. Semin Ophthalmol. 2013;28:191–201.
• The authors’ first review of educational interventions to improve glaucoma medication adherence through 2011.
- Stead LF, Bergson G, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2008;2:CD000165.
- Friedman DS, Jampel HD, Congdon NG, et al. The TRAVATAN Dosing Aid accurately records when drops are taken. Am J Ophthalmol. 2007;143:699–701.
- Lim MC, Watnik MR, Imson KR, et al. Adherence to glaucoma medication: the effect of interventions and association with personality type. J Glaucoma. 2013;22:439–446.
- Sayner R, Carpenter DM, Blalock SJ, et al. Accuracy of patient-reported adherence to glaucoma medications on a visual analog scale compared with electronic monitors. Clin Ther. 2015;37:1975–1985.
- Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996;17:1–12.
- Deeks JJ, Dinnes J, D’Amico R, et al. International stroke trial collaborative G, European carotid surgery trial collaborative G. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7:iii-x, 1-173.
- Okeke CO, Quigley HA, Jampel HD, et al. Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients. Ophthalmology. 2009;116:2286–2293.
•• A successful intervention for improving glaucoma medication adherence that individualized the care to meet each patient’s needs.
- Sheppard J, Warner J, Kelley K. An evaluation of the effectiveness of a nurse-led glaucoma monitoring clinic. Ophthalmic Nurs Int J Ophthalmic Nurs. 2003;7:15–21.
- Norell SE. Improving medication compliance: a randomised clinical trial. Br Med J. 1979;2:1031–1033.
- Muir KW, Ventura A, Stinnett SS, et al. The influence of health literacy level on an educational intervention to improve glaucoma medication adherence. Patient Educ Couns. 2012;87:160–164.
- Cook PF, Bremer RW, Ayala AJ, et al. Feasibility of motivational interviewing delivered by a glaucoma educator to improve medication adherence. Clin Ophthalmol. 2010;4:1091–1101.
- Rendell J. Effect of health education on patient’s beliefs about glaucoma and compliance. Insight. 2000;25:112–118.
- Chen X, Chen Y, Sun X. Notable role of glaucoma club on patients’ knowledge of glaucoma. Clin Experiment Ophthalmol. 2009;37:590–594.
- Blondeau P, Carbonneau M, Esper P, et al. A 2-hour information session and patient recall has minimal impact on glaucoma-treatment persistence in a mature practice. J Glaucoma. 2012;21(6):379–382.
- Cate H, Bhattacharya D, Clark A, et al. Improving adherence to glaucoma medication: a randomised controlled trial of a patient-centred intervention (The Norwich Adherence Glaucoma Study). BMC Ophthalmol. 2014;14:32.
- Beckers HJ, Webers CA, Busch MJ, et al. Dutch adherence study G. Adherence improvement in Dutch glaucoma patients: a randomized controlled trial. Acta Ophthalmol. 2013;91:610–618.
- Glanz K, Beck AD, Bundy L, et al. Impact of a health communication intervention to improve glaucoma treatment adherence. Results of the interactive study to increase glaucoma adherence to treatment trial. Arch Ophthalmol. 2012;130:1252–1258.
- Gray TA, Fenerty C, Harper R, et al. Individualised patient care as an adjunct to standard care for promoting adherence to ocular hypotensive therapy: an exploratory randomised controlled trial. Eye (Lond). 2012;26:407–417.
•• One of the most comprehensive, promising approaches to improving glaucoma medication adherence.
- McVeigh KA, Vakros G. The eye drop chart: a pilot study for improving administration of and compliance with topical treatments in glaucoma patients. Clin Ophthalmol. 2015;9:813–819.
- Dreer LE, Owsley C, Campbell L, et al. Feasibility, patient acceptability, and preliminary efficacy of a culturally informed, health promotion program to improve glaucoma medication adherence among African Americans: “Glaucoma Management Optimism for African Americans Living with Glaucoma” (GOAL). Curr Eye Res. 2016;41(1):50–58.
- Richardson C, Brunton L, Olleveant N, et al. A study to assess the feasibility of undertaking a randomized controlled trial of adherence with eye drops in glaucoma patients. Patient Prefer Adherence. 2013;7:1025–1039.
- Lunnela J, Kaariainen M, Kyngas H. Web-based intervention for improving adherence of people with glaucoma. J Nurs Healthc Chronic Illn. 2011;3:119–129.
- Musch DC, Gillespie BW, Niziol LM, et al. Intraocular pressure control and long-term visual field loss in the collaborative initial glaucoma treatment study. Ophthalmology. 2011;118:1766–1773.
- Sleath B, Blalock SJ, Covert D, et al. Patient race, reported problems in using glaucoma medications, and adherence. ISRN Ophthalmol. 2012;2012:1–7.
- Consumer Assessment of Healthcare Providers & Systems (CAHPS). [cited 2015 June 2]. Available from: https://www.cms.gov/Research-Statistics-Data-and-Systems/Research/CAHPS/index.html?redirect=/cahps
- Barbosa CD, Balp MM, Kulich K, et al. A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence. Patient Prefer Adherence. 2012;6:39–48.
- Lundahl B, Moleni T, Burke BL, et al. Motivational interviewing in medical care settings: a systematic review and meta-analysis of randomized controlled trials. Patient Educ Couns. 2013;93:157–168.
- Sleath B, Sayner R, Blalock SJ, et al. Patient question-asking about glaucoma and glaucoma medications during videotaped medical visits. Health Commun. 2015;30:660–668.
- Sleath B, Blalock SJ, Carpenter DM, et al. Provider education about glaucoma and glaucoma medications during videotaped medical visits. J Ophthalmol. 2014;2014:1–7.
- Sleath B, Blalock SJ, Carpenter DM, et al. Ophthalmologist-patient communication, self-efficacy, and glaucoma medication adherence. Ophthalmology. 2015;122:748–754.
- Boland MV, Chang DS, Frazier T, et al. Automated telecommunication-based reminders and adherence with once-daily glaucoma medication dosing: the automated dosing reminder study. JAMA Ophthalmol. 2014;132:845–850.
- Saeedi OJ, Luzuriaga C, Ellish N, et al. Potential limitations of E-mail and text messaging in improving adherence in glaucoma and ocular hypertension. J Glaucoma. 2015;24:e95–e102.
- Noar SM, Benac CN, Harris MS. Does tailoring matter? Meta-analytic review of tailored print health behavior change interventions. Psychol Bull. 2007;133:673–693.
- Neville LM, O’Hara B, Milat AJ. Computer-tailored dietary behaviour change interventions: a systematic review. Health Educ Res. 2009;24:699–720.
- Richards KC, Enderlin CA, Beck C, et al. Tailored biobehavioral interventions: a literature review and synthesis. Res Theory Nurs Pract. 2007;21:271–285.
- Strecher VJ, McClure JB, Alexander GL, et al. Web-based smoking-cessation programs: results of a randomized trial. Am J Prev Med. 2008;34:373–381.
- Djafari F, Lesk MR, Harasymowycz PJ, et al. Determinants of adherence to glaucoma medical therapy in a long-term patient population. J Glaucoma. 2009;18:238–243.
- Robin AL, Covert D. Does adjunctive glaucoma therapy affect adherence to the initial primary therapy? Ophthalmology. 2005;112:863–868.
- Robin AL, Novack GD, Covert DW, et al. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol. 2007;144:533–540.